A case of giant expanding cephalhematoma: does the administration of blood coagulation factor XIII reverse symptoms?

Surg Neurol. 2003 Aug;60(2):138-41; discussion 141. doi: 10.1016/s0090-3019(03)00191-5.

Abstract

Background: The mechanism of continuous massive hemorrhage into the subperiosteal space in children without coagulation defects is unknown. We report a case of giant expanding cephalhematoma reversed by the administration of blood coagulation factor XIII concentrate.

Method: The patient was an 8-year-old boy with a history of minor head trauma who developed a giant expanding cephalhematoma with intraorbital extension. The laboratory data showed severe anemia, but a routine blood coagulation test showed no abnormalities except for a low factor XIII level.

Result: The administration of factor XIII concentrate completely reversed the symptoms in 2 weeks.

Conclusion: We speculate that one of the possible mechanisms of cephalhematoma expansion without blood coagulation defects might be acquired factor XIII deficiency from severe hemorrhage in a hematoma.

Publication types

  • Case Reports

MeSH terms

  • Bone Diseases / complications
  • Bone Diseases / drug therapy
  • Child
  • Diplopia / etiology
  • Factor XIII / administration & dosage
  • Factor XIII / therapeutic use*
  • Headache / etiology
  • Hematoma / complications*
  • Hematoma / drug therapy*
  • Hematoma / pathology
  • Humans
  • Male
  • Periosteum*
  • Skull / pathology*

Substances

  • Factor XIII